EUVIMEDEUVIMED entdecken
Multizentrische Studie

DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer

Helena Rodríguez-Lloveras, Carles Zafon, Carmela Iglesias, Jennifer Marcos-Ruiz, Joan Gil, Anna Rueda-Pujol, Lorena González, Regina Mayor, Esther N Klein Hesselink, Bettien M van Hemel, Cristina Carrato, Cecília Perelló-Fabregat und 15 weitere

Thyroid® · 2025

DOI: 10.1089/thy.2024.0303 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Thyroid®, 2025. Verfasst von Helena Rodríguez-Lloveras und 26 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Tumors Group, Translational Program in Cancer Research (CARE), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. Hauptthemen laut MEDLINE: DNA Methylation, Thyroid Neoplasms, Adenocarcinoma, Follicular, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationThyroid NeoplasmsAdenocarcinoma, FollicularThyroid Cancer, PapillaryHumansFemaleMaleRetrospective StudiesPrognosisMiddle AgedAdultCpG IslandsAgedNeoplasm MetastasisDisease ProgressionLymphatic Metastasis

Stichwörter der Autor:innen

DNA methylationDTC progressiondifferentiated thyroid cancer (DTC)distant metastases (DM)prognostic biomarkers

Autor:innen und Institutionen

  • Endocrine Tumors Group, Translational Program in Cancer Research (CARE), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
  • Endocrinology and Nutrition Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Pathology Department, Vall d'Hebron Universtiy Hospital, Barcelona, Spain.
  • Centre for Biomedical Network Research on Rare Diseases (CIBERER), Unit 747, Institute of Health Carlos III (ISCIII), Madrid, Spain.
  • Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
  • Endocrinology Department, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

ORCID-Profile: Cristina Montero-Conde, Jordi L Reverter, Manel Puig-Domingo

Zitieren

APA

Rodríguez-Lloveras, H., Zafon, C., Iglesias, C., Marcos-Ruiz, J., Gil, J., Rueda-Pujol, A., González, L., Mayor, R., Klein Hesselink, E. N., van Hemel, B. M., Carrato, C., Perelló-Fabregat, C., Hernández-Losa, J., Somoza, R., Pluvinet, R., Sánchez-Herrero, J. F., Sumoy, L., Seoane, J., Riesco-Eizaguirre, G., …, & Jordà, M. (2025). DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer. Thyroid®. https://doi.org/10.1089/thy.2024.0303

Vancouver

Rodríguez-Lloveras H, Zafon C, Iglesias C, Marcos-Ruiz J, Gil J, Rueda-Pujol A, et al. DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer. Thyroid®. 2025. doi:10.1089/thy.2024.0303

BibTeX
@article{RodrguezLloveras2025,
  author = {Rodríguez-Lloveras, Helena and Zafon, Carles and Iglesias, Carmela and Marcos-Ruiz, Jennifer and Gil, Joan and Rueda-Pujol, Anna and González, Lorena and Mayor, Regina and Klein Hesselink, Esther N and van Hemel, Bettien M and Carrato, Cristina and Perelló-Fabregat, Cecília and Hernández-Losa, Javier and Somoza, Rosa and Pluvinet, Raquel and Sánchez-Herrero, Jose F and Sumoy, Lauro and Seoane, Joan and Riesco-Eizaguirre, Garcilaso and Montero-Conde, Cristina and Robledo, Mercedes and Hernando, Jorge and Capdevila, Jaume and Reverter, Jordi L and Puig-Domingo, Manel and Links, Thera P and Jordà, Mireia},
  title = {DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer},
  journal = {Thyroid®},
  year = {2025},
  doi = {10.1089/thy.2024.0303}
}
Kostenlos starten →